Emerging role of adipokines in systemic lupus erythematosus

[1]  G. Nagaraju,et al.  The role of adiponectin in obesity-associated female-specific carcinogenesis. , 2016, Cytokine & growth factor reviews.

[2]  M. Tohidi,et al.  Association between urinary adiponectin level and renal involvement in systemic lupus erythematous , 2016, International journal of rheumatic diseases.

[3]  Meilian Liu,et al.  Adiponectin: a versatile player of innate immunity. , 2016, Journal of molecular cell biology.

[4]  W. Petri,et al.  Leptin Regulation of Immune Responses. , 2016, Trends in molecular medicine.

[5]  A. Rossary,et al.  Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity. , 2015, Life sciences.

[6]  Ruixue Leng,et al.  Plasma/Serum Leptin Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis. , 2015, Archives of medical research.

[7]  S. Landas,et al.  Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus. , 2015, Clinical Immunology.

[8]  R. Liu,et al.  Leptin and Neutrophil‐Activating Peptide 2 Promote Mesenchymal Stem Cell Senescence Through Activation of the Phosphatidylinositol 3‐Kinase/Akt Pathway in Patients With Systemic Lupus Erythematosus , 2015, Arthritis & rheumatology.

[9]  Y. Ni,et al.  Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease , 2015, Biomolecules.

[10]  Peng Li,et al.  Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis , 2015, Clinical Rheumatology.

[11]  Tianfu Wu,et al.  Resistin as a potential marker of renal disease in lupus nephritis , 2015, Clinical and experimental immunology.

[12]  Nilzio Antônio da Silva,et al.  Leptina e adiponectina no lúpus eritematoso sistêmico: correlações clínicas e laboratoriais , 2015 .

[13]  B. Zabel,et al.  The Expression and Regulation of Chemerin in the Epidermis , 2015, PloS one.

[14]  A. Yousuf,et al.  Serum Leptin Levels, Leptin Receptor Gene (LEPR) Polymorphism, and the Risk of Systemic Lupus Erythematosus in Kashmiri Population , 2015, Immunological investigations.

[15]  H. Krauss,et al.  Novel adipokines: their potential role in the pathogenesis of obesity and metabolic disorders. , 2015, Postepy higieny i medycyny doswiadczalnej.

[16]  A. La Cava,et al.  Leptin Enhances Availability of Apoptotic Cell-Derived Self-Antigen in Systemic Lupus Erythematosus , 2014, PloS one.

[17]  G. Ferraccioli,et al.  Obesity as a Risk and Severity Factor in Rheumatic Diseases (Autoimmune Chronic Inflammatory Diseases) , 2014, Front. Immunol..

[18]  Y. Shoenfeld,et al.  Obesity in autoimmune diseases: not a passive bystander. , 2014, Autoimmunity reviews.

[19]  S. Barni,et al.  Natural History of Malignant Bone Disease in Hepatocellular Carcinoma: Final Results of a Multicenter Bone Metastasis Survey , 2014, PloS one.

[20]  J. Buyon,et al.  Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus. , 2014, Clinical immunology.

[21]  S. Crowe,et al.  Monocytes as Regulators of Inflammation and HIV-Related Comorbidities during cART , 2014, Journal of immunology research.

[22]  Xiaofei Xu,et al.  Ultraviolet B irradiation induces skin accumulation of plasmacytoid dendritic cells: A possible role for chemerin , 2014, Autoimmunity.

[23]  M. Sperandio,et al.  Endothelial Cell–Derived Chemerin Promotes Dendritic Cell Transmigration , 2014, The Journal of Immunology.

[24]  B. Zabel,et al.  Chemerin regulation and role in host defense. , 2014, American journal of clinical and experimental immunology.

[25]  J. Gómez-Reino,et al.  Adipokines, Metabolic Syndrome and Rheumatic Diseases , 2014, Journal of immunology research.

[26]  Tomomi Sato,et al.  Deficient Leptin Signaling Ameliorates Systemic Lupus Erythematosus Lesions in MRL/Mp-Faslpr Mice , 2014, The Journal of Immunology.

[27]  Min Zhang,et al.  Association between leptin and systemic lupus erythematosus , 2014, Rheumatology International.

[28]  F. Shi,et al.  Leptin promotes lupus T-cell autoimmunity. , 2013, Clinical immunology.

[29]  E. Barroso,et al.  Metabolic Alterations and Increased Liver mTOR Expression Precede the Development of Autoimmune Disease in a Murine Model of Lupus Erythematosus , 2012, PloS one.

[30]  D. Binda,et al.  Adiponectin in autoimmune diseases. , 2012, Current medicinal chemistry.

[31]  Enrica Baraldi,et al.  Reproductive Status Is Associated with the Severity of Fibrosis in Women with Hepatitis C , 2012, PloS one.

[32]  J. Gómez-Reino,et al.  Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases , 2012, Mediators of inflammation.

[33]  A. Santoni,et al.  Interplay between Human Cytomegalovirus and Intrinsic/Innate Host Responses: A Complex Bidirectional Relationship , 2012, Mediators of inflammation.

[34]  B. Okopień,et al.  The role of adipokines in connective tissue diseases , 2012, European Journal of Nutrition.

[35]  D. Gladman,et al.  Prevalence and Risk Factors for Liver Biochemical Abnormalities in Canadian Patients with Systemic Lupus Erythematosus , 2012, The Journal of Rheumatology.

[36]  Nilzio Antônio da Silva,et al.  Possível papel das adipocinas no lúpus eritematoso sistêmico e na artrite reumatoide , 2012 .

[37]  Li-Ling Wu,et al.  Adiponectin and interleukin-6 in inflammation-associated disease. , 2012, Vitamins and hormones.

[38]  F. Cacciapaglia,et al.  Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus , 2013, Internal and Emergency Medicine.

[39]  M. Lazar,et al.  Resistin Levels in Lupus and Associations with Disease-specific Measures, Insulin Resistance, and Coronary Calcification , 2011, The Journal of Rheumatology.

[40]  J. Gómez-Reino,et al.  Beyond Fat Mass: Exploring the Role of Adipokines in Rheumatic Diseases , 2011, TheScientificWorldJournal.

[41]  M. Parmentier,et al.  Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. , 2011, Cytokine & growth factor reviews.

[42]  M. Weisman,et al.  High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. , 2011, Annals of the rheumatic diseases.

[43]  M. Parmentier,et al.  The possible role of ChemR23/Chemerin axis in the recruitment of dendritic cells in lupus nephritis. , 2011, Kidney international.

[44]  G. Kitas,et al.  Obesity in rheumatoid arthritis. , 2011, Rheumatology.

[45]  Y. Takemura,et al.  Modulation of Lupus Phenotype by Adiponectin Deficiency in Autoimmune Mouse Models , 2011, Journal of Clinical Immunology.

[46]  Y. Figenschau,et al.  Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin21-157 , 2010, Arthritis research & therapy.

[47]  P. Saas,et al.  Elevated Adiponectin Serum Levels in Women with Systemic Autoimmune Diseases , 2010, Mediators of inflammation.

[48]  P. Stenvinkel,et al.  Clinical importance of an elevated circulating chemerin level in incident dialysis patients. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[49]  Matthew C. Ernst,et al.  Chemerin: at the crossroads of inflammation and obesity , 2010, Trends in Endocrinology & Metabolism.

[50]  Mimi Y. Kim,et al.  Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus. , 2010, Atherosclerosis.

[51]  K. Goralski,et al.  Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. , 2010, Endocrinology.

[52]  C. Suh,et al.  Leptin and ghrelin in Korean systemic lupus erythematosus , 2010, Lupus.

[53]  H. Randeva,et al.  Identification of Chemerin Receptor (ChemR23) in Human Endothelial Cells: , 2009 .

[54]  A. Stofkova.  Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. , 2010, Endocrine regulations.

[55]  M. Fasshauer,et al.  Serum Levels of the Adipokine Chemerin in Relation to Renal Function , 2009, Diabetes Care.

[56]  A. Stofkova.  Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. , 2009, Endocrine regulations.

[57]  P. Arner,et al.  Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle Cells , 2009, Diabetes.

[58]  P. Raggi,et al.  Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis , 2009, Lupus.

[59]  B. Rovin,et al.  Induction of chemokine expression by adiponectin in vitro is isoform dependent. , 2009, Translational research : the journal of laboratory and clinical medicine.

[60]  Rodolfo Gomez,et al.  Adipokines in the skeleton: influence on cartilage function and joint degenerative diseases. , 2009, Journal of molecular endocrinology.

[61]  H. Randeva,et al.  Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin , 2009, Diabetes.

[62]  F. Cacciapaglia,et al.  Adipokines and Systemic Lupus Erythematosus: Relationship with Metabolic Syndrome and Cardiovascular Disease Risk Factors , 2009, The Journal of Rheumatology.

[63]  M. Parmentier,et al.  Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment , 2009, The Journal of experimental medicine.

[64]  K. Walsh,et al.  The Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Ameliorates Murine Lupus by Induction of Adiponectin1 , 2009, The Journal of Immunology.

[65]  J. D. de Sanctis,et al.  Serum adipokine levels in patients with systemic lupus erythematosus , 2009, Autoimmunity.

[66]  J. Bargman,et al.  Adipokines as novel biomarkers in paediatric systemic lupus erythematosus. , 2008, Rheumatology.

[67]  G. Fantuzzi.  Adiponectin and inflammation: consensus and controversy. , 2008, The Journal of allergy and clinical immunology.

[68]  M. Bokarewa,et al.  Role of resistin as a marker of inflammation in systemic lupus erythematosus , 2008, Arthritis research & therapy.

[69]  M. Wislowska,et al.  Serum leptin in systemic lupus erythematosus , 2008, Rheumatology International.

[70]  T. Kadowaki,et al.  Adiponectin and adiponectin receptors in obesity-linked insulin resistance. , 2007, Novartis Foundation symposium.

[71]  R. Said,et al.  Role for leptin and prolactin in human juvenile rheumatic diseases. , 2007, Pakistan journal of biological sciences : PJBS.

[72]  R. Henry,et al.  Adiponectin in health and disease , 2007, Diabetes, obesity & metabolism.

[73]  D. Wendling,et al.  The contribution of adipose tissue and adipokines to inflammation in joint diseases. , 2007, Current medicinal chemistry.

[74]  S. Kihara,et al.  Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. , 2007, The Journal of clinical investigation.

[75]  P. Raggi,et al.  High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors , 2006, Annals of the rheumatic diseases.

[76]  S. Yaturu,et al.  Plasma and urine levels of resistin and adiponectin in chronic kidney disease. , 2007, Cytokine.

[77]  J. Bełtowski,et al.  Leptin and atherosclerosis. , 2006, Atherosclerosis.

[78]  M. Ryan,et al.  Insulin Resistance and Obesity in a Mouse Model of Systemic Lupus Erythematosus , 2006, Hypertension.

[79]  Herbert Tilg,et al.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.

[80]  E. Butcher,et al.  Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-beta and TLR ligands. , 2006, Experimental hematology.

[81]  H. Sugiyama,et al.  Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. , 2006, The Journal of rheumatology.

[82]  B. Rovin,et al.  Chemokine induction by the adipocyte-derived cytokine adiponectin. , 2006, Clinical immunology.

[83]  J. Whitehead,et al.  Adiponectin – a key adipokine in the metabolic syndrome , 2006, Diabetes, obesity & metabolism.

[84]  U. Müller-Ladner,et al.  Different effects of adiponectin isoforms in human monocytic cells , 2006, Journal of leukocyte biology.

[85]  Shinji Kihara,et al.  Adiponectin: a key adipocytokine in metabolic syndrome. , 2006, Clinical science.

[86]  A. Greenberg,et al.  Obesity and the role of adipose tissue in inflammation and metabolism. , 2006, The American journal of clinical nutrition.

[87]  E. Butcher,et al.  Chemerin Activation by Serine Proteases of the Coagulation, Fibrinolytic, and Inflammatory Cascades* , 2005, Journal of Biological Chemistry.

[88]  H. Nagaraja,et al.  Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. , 2005, Kidney international.

[89]  A. Mantovani,et al.  Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin , 2005, The Journal of experimental medicine.

[90]  F. Casanueva,et al.  Leptin, from fat to inflammation: old questions and new insights , 2005, FEBS letters.

[91]  E. Butcher,et al.  Chemokine-Like Receptor 1 Expression and Chemerin-Directed Chemotaxis Distinguish Plasmacytoid from Myeloid Dendritic Cells in Human Blood1 , 2005, The Journal of Immunology.

[92]  B. Okopień,et al.  [Adipose tissue: a new endocrine organ]. , 2005, Przeglad lekarski.

[93]  J. Schölmerich,et al.  Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis , 2004, Annals of the rheumatic diseases.

[94]  G. Matarese,et al.  The weight of leptin in immunity , 2004, Nature Reviews Immunology.

[95]  Marc Parmentier,et al.  Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids , 2003, The Journal of experimental medicine.

[96]  P. Shepherd,et al.  Glucose-dependent Regulation of Cholesterol Ester Metabolism in Macrophages by Insulin and Leptin* , 2002, The Journal of Biological Chemistry.

[97]  A. Garcia-Gonzalez,et al.  Serum leptin levels in women with systemic lupus erythematosus , 2002, Rheumatology International.

[98]  M. Stumvoll,et al.  Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. , 2002, Diabetes.

[99]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[100]  R. Busse,et al.  Leptin induces oxidative stress in human endothelial cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[101]  V. Sánchez-Margalet,et al.  Human leptin stimulates proliferation and activation of human circulating monocytes. , 1999, Cellular immunology.

[102]  Stephen R. Bloom,et al.  Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression , 1998, Nature.

[103]  C. Mantzoros,et al.  Role of leptin in the neuroendocrine response to fasting , 1996, Nature.

[104]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.